Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Active, not recruiting
NCT03383692
Study of DS-8201a for Participants With Advanced Solid Malignant Tumors
40
Enrollment(s)
10
Study location(s)
Interventional (Phase I)
Neoplasm Metastasis
Completed
NCT04420598
DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
41
Enrollment(s)
19
Study location(s)
Interventional (Phase II)
Advanced Breast Cancer
HER2-positive Breast Cancer
Brain Metastases
Leptomeningeal Metastasis
Not yet recruiting
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000
Enrollment(s)
10
Study location(s)
Interventional (Phase IV)
Deep Vein Thrombosis
Pulmonary Embolism
Recruiting
NCT03129490
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
11,000
Enrollment(s)
22
Study location(s)
Interventional (Phase IV)
Atrial Fibrillation
Atrial Flutter
Active, not recruiting
NCT05594082
Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer
150
Enrollment(s)
1
Study location(s)
Observational
Breast Cancer
Not yet recruiting
NCT05779059
Prasugrel Or Ticagrelor De-escalation in NSTE-ACS
50
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Non ST Segment Elevation Acute Coronary Syndrome
Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Unstable Angina
Active, not recruiting
NCT01717586
Pravastatin for Prevention of Preeclampsia
48
Enrollment(s)
3
Study location(s)
Interventional (Phase I)
Preeclampsia
Terminated
NCT02484261
Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
10
Enrollment(s)
1
Study location(s)
Interventional (Phase I)
Leukemia
26
27
28
29
30